Table 1.
Demographic and practice experience | Value |
---|---|
Mean (range) age, years | 58 (42–82) |
Male sex, n (%) | 21 (62) |
Mean (range) years in practice | 25 (0–45) |
Degree, n (%) | |
MD | 24 (71) |
PhD | 6 (18) |
DNP | 2 (6) |
PharmD | 2 (6) |
Involved in schizophrenia, bipolar disorder, or major depressive disorder research (within previous 5 years), n (%) | 22 (65) |
Mean (range) research experience, years | 22 (0–52) |
NIMH/NIH research grant as principal investigator, n (%) | 15 (44) |
Principal investigator for an industry-sponsored grant, n (%) | 20 (59) |
| |
Practice environment | Value |
| |
Proportion of time spent seeing patients, n (%) | |
All/majority of the time | 12 (36) |
50% of the time | 7 (21) |
25% of the time | 10 (29) |
<10% of the time | 5 (15) |
Practice setting(s) where significant number of patients seen,a n (%) | |
Private practice | 8 (25) |
Public sector | 11 (34) |
Academic clinical or research setting | 23 (69) |
Mean percentage of time (range) spent treating or supervising the treatment of patients, by disease | |
Schizophrenia/schizoaffective disorder | 30 (0–100) |
Bipolar disorder | 25 (0–75) |
Major depressive disorder | 24 (0–60) |
Mean percentage of patients (range) with insurance coverage | |
Private insurance | 30 (0–100) |
Medicaid | 33 (0–75) |
Medicare | 22 (0–70) |
Uninsured | 15 (0–70) |
Mean percentage of patients (range) treated by age group | |
<18 years | 10 (0–75) |
18–34 years | 35 (0–55) |
35–65 years | 41 (0–70) |
>65 years | 13 (0–65) |
Mean percentage of patients (range) in practice currently receiving LAI, by disease | |
Schizophrenia/schizoaffective disorder | 33 (0–100) |
Bipolar disorder | 11 (0–40) |
Note:
Some experts may have provided >1 response.
Abbreviations: LAI, long-acting injectable antipsychotic; NIMH/NIH, National Institute of Mental Health/National Institutes of Health.